Differences in Characteristics of Headache Patients With a Positive or Negative FRT: a Cross-sectional Comparison.
Differences in Headache Characteristics of a Subgroup of Cervicogenic Headache Patients With a Positive or Negative FRT: a Cross-sectional Comparison.
1 other identifier
observational
100
1 country
1
Brief Summary
An observational study will be conducted to evaluate the differences in headache characteristics between a subgroup of cervicogenic headache patients with a positive and negative flexion-rotation test at the C1-C2 level. Differences may guide future treatment allocation and the use of more individualized treatment options.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 6, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
November 18, 2023
November 1, 2023
3.4 years
July 6, 2023
November 13, 2023
Conditions
Outcome Measures
Primary Outcomes (7)
Headache pain intensity
Subjects will have to report their actual pain complaints on a numeric pain rating scale (NPRS) ranging from 0 (no pain) to 10 (worst pain) at baseline testing.
Baseline
Headache frequency
Frequency of headache attacks will be registered
Baseline
Headache duration
Duration of headache attacks will be registered
Baseline
Headache related disability
Headache related disability will be questioned using the Henry Ford Headache Disability Index (HDI). The total score ranges from 0-100. The higher the score, the more disabilitating the headache is for the patient.
Baseline
Headache related impact
Headache related disability will be questioned using the Headache Impact Test (HIT-6) questionnaire. The total score can range from 36 to 78, with a higher score indicating the headache has more impact on daily life.
Baseline
Neck pain intensity
Subjects will have to report their actual pain complaints on a numeric pain rating scale (NPRS) ranging from 0 (no pain) to 10 (worst pain) at baseline testing.
Baseline
Neck disability
Neck pain related disability will be questioned using the NDI (Neck Disability Index). The total score ranges from 0 to 50, with a higher score indicating more disability.
Baseline
Secondary Outcomes (8)
Pain Pressure Thresholds (PPTs)
Baseline
Joint Position Error
Baseline
Global active range of motion of the cervical spine.
Baseline
Motor control of the cervical spine (craniocervical flexion test)
Baseline
Psychosocial headache related parameters: central sensitization by using the Central Sensitization Index (CSI).
Baseline
- +3 more secondary outcomes
Study Arms (2)
Cervicogenic headache with positive flexion-rotation test
Diagnosis of cervicogenic headache according to the ICHD-3 criteria. Age: 18+ years Headache for at least 1 day/week for at least 3 months Limited mobility of the neck Positive flexion-rotation test (\<32 degrees on the left/right side or a difference of 10 degrees or more between left and right side) NPRS \> 3/10
Cervicogenic headache without positive flexion-rotation test
Diagnosis of cervicogenic headache according to the ICHD-3 criteria Age: 18+ years Headache for at least 1 day/week for at least 3 months Limited mobility of the neck Negative flexion-rotation test (\>32 degrees on the left/right side or a difference of less than 10 degrees between left and right side) NPRS \> 3/10
Interventions
No intervention
Eligibility Criteria
Participants with chronic headache, compliant to the ICHD-3 criteria for cervicogenic headache.
You may qualify if:
- Diagnosis of cervicogenic headache according to the ICHD-3 criteria:
- A. Any headache fulfilling criterion C B. Clinical and/or imaging evidence1 of a disorder or lesion within the cervical spine or soft tissues of the neck, known to be able to cause headache2
- C. Evidence of causation demonstrated by at least two of the following:
- headache has developed in temporal relation to the onset of the cervical disorder or appearance of the lesion
- headache has significantly improved or resolved in parallel with improvement in or resolution of the cervical disorder or lesion
- cervical range of motion is reduced, and headache is made significantly worse by provocative manœuvres
- headache is abolished following diagnostic blockade of a cervical structure or its nerve supply D. Not better accounted for by another ICHD-3 diagnosis
- Age: 18+ years Headache for at least 1 day/week for at least 3 months Limited mobility of the neck NPRS \> 3/10
You may not qualify if:
- Primary headache forms: migraine, TTH
- Other secondary headaches that do not comply with the ICDH-3 criteria for CH
- Whiplash or other traumatic incident in the past
- Pregnancy or given birth in the last year
- Previous head, neck or shoulder surgery
- Cervical radiculopathy complaints
- Receiving other treatments for headache or neck pain (physical therapy/ostheopathy/chiropraxie...) in the previous month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
University Ghent - campus UZ Ghent - Rehabilitation Sciences B3
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Cagnie, Prof. dr.
University Ghent
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2023
First Posted
November 18, 2023
Study Start
July 1, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
No data will be shared outside the research team.